STOCK TITAN

Ionis to present at 40th Annual J.P. Morgan Healthcare conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Ionis Pharmaceuticals announced that CEO Brett P. Monia, Ph.D., will provide a company overview at the virtual 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 9:45 a.m. ET. A live webcast will be accessible via the Investors & Media section of their website, with a replay available within 48 hours. Ionis has over 30 years of leadership in RNA-targeted therapy and boasts a strong late-stage pipeline focusing on neurological and cardiometabolic treatments.

Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., Jan. 5, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the virtual 40th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. ET on Wednesday, January 12, 2022.

A live webcast of the presentation will be available on the Investors & Media section of the Ionis website. The replay will be available within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies.

To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-40th-annual-jp-morgan-healthcare-conference-301454178.html

SOURCE Ionis Pharmaceuticals, Inc.

FAQ

What time will Ionis Pharmaceuticals present at the J.P. Morgan Healthcare Conference?

Ionis Pharmaceuticals will present at 9:45 a.m. ET on January 12, 2022.

Who will present for Ionis Pharmaceuticals at the conference?

Brett P. Monia, Ph.D., the CEO of Ionis Pharmaceuticals, will present.

Where can I watch the Ionis Pharmaceuticals presentation?

The presentation will be available via a live webcast on the Investors & Media section of the Ionis website.

Will there be a replay of the Ionis Pharmaceuticals presentation?

Yes, the replay will be available within 48 hours after the live presentation.

What is Ionis Pharmaceuticals known for?

Ionis Pharmaceuticals is a leader in RNA-targeted therapy and has a strong pipeline in neurological and cardiometabolic treatments.

Ionis Pharmaceuticals, Inc.

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Stock Data

5.55B
154.36M
0.77%
103.25%
7%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CARLSBAD